As of 2025-05-25, the Intrinsic Value of Sabra Health Care REIT Inc (SBRA) is 20.87 USD. This SBRA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 17.44 USD, the upside of Sabra Health Care REIT Inc is 19.70%.
The range of the Intrinsic Value is 9.83 - 67.11 USD
Based on its market price of 17.44 USD and our intrinsic valuation, Sabra Health Care REIT Inc (SBRA) is undervalued by 19.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 9.83 - 67.11 | 20.87 | 19.7% |
| DCF (Growth 10y) | 11.57 - 67.61 | 22.45 | 28.8% |
| DCF (EBITDA 5y) | 13.09 - 18.36 | 15.33 | -12.1% |
| DCF (EBITDA 10y) | 14.33 - 21.72 | 17.51 | 0.4% |
| Fair Value | 14.79 - 14.79 | 14.79 | -15.20% |
| P/E | 15.65 - 19.58 | 17.65 | 1.2% |
| EV/EBITDA | 8.70 - 21.64 | 14.51 | -16.8% |
| EPV | 18.26 - 30.19 | 24.22 | 38.9% |
| DDM - Stable | 6.92 - 25.16 | 16.04 | -8.0% |
| DDM - Multi | 10.43 - 24.38 | 14.10 | -19.2% |
| Market Cap (mil) | 4,149.67 |
| Beta | 0.10 |
| Outstanding shares (mil) | 237.94 |
| Enterprise Value (mil) | 6,520.92 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.05% |
| Cost of Debt | 5.52% |
| WACC | 6.46% |